Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Supporters often emphasize the potential for meaningful therapeutic benefits, particularly in diseases where conventional medications have proven inadequate. However, this is to assess the substantial financial burden associated with CPI stem cell the